Last update 08 May 2025

4B TECHNOLOGIES LIMITED

Private Company|2017|Hong Kong SAR, China

Overview

Tags

Nervous System Diseases
Other Diseases
Endocrinology and Metabolic Disease
Monoclonal antibody
Antibody
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases15
Endocrinology and Metabolic Disease5
Top 5 Drug TypeCount
Monoclonal antibody6
Antibody3
Small molecule drug2
Unknown2
Gene therapy1
Top 5 TargetCount
TrkB(Neurotrophic tyrosine kinase receptor type 2)2
TrkA(Nerve growth factor receptor Trk-A)2
CSF-1R(Colony stimulating factor 1 receptor)1
Lp-PLA2(Lipoprotein-associated phospholipase A2)1
SLC3A2(solute carrier family 3 member 2)1

Related

17
Drugs associated with 4B TECHNOLOGIES LIMITED
Enrupatinib
Target
CSF-1R
Mechanism
CSF-1R antagonists
Active Org.
Elixiron Immunotherapeutics, Inc.Elixiron Immunotherapeutics, Inc. [+1]
Originator Org.
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., Limited
Active Indication
Alzheimer Disease [+3]
Inactive Indication-
Drug Highest PhasePhase 2/3
First Approval Ctry. / Loc.-
First Approval Date-
FB-1006
Target-
Mechanism-
Active Org.
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., Limited
Originator Org.
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., Limited
Active Indication
Amyotrophic Lateral Sclerosis
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
FB-1003
Target
TrkA
Mechanism
TrkA activators
Active Org.
Fubei Biotechnology Suzhou Co. Ltd.Fubei Biotechnology Suzhou Co. Ltd. [+1]
Originator Org.
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., Limited
Active Indication
Chronic Pain
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
5
Clinical Trials associated with 4B TECHNOLOGIES LIMITED
CTR20241755
/ RecruitingPhase 1
FB1001在急性视神经病变患者中单、多次给药，观察临床安全性、耐受性、药代动力学特征及探索有效性的，开放I期临床
[Translation] Phase I clinical trial of FB1001 in patients with acute optic neuropathy using single or multiple administrations to observe clinical safety, tolerability, pharmacokinetic characteristics and explore efficacy
NCT06506305
/ Not yet recruitingPhase 1IIT
A Single/Multiple Dose Escalation, Open-Labeled, Phase I Clinical Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of FB1001 in Patients With Acute Optic Neuropathy
NCT06343714
/ Not yet recruitingPhase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Escalating Single and Multiple Doses of FB1003 in the Healthy Subjects
100 Clinical Results associated with 4B TECHNOLOGIES LIMITED
Login to view more data
0 Patents (Medical) associated with 4B TECHNOLOGIES LIMITED
Login to view more data
100 Deals associated with 4B TECHNOLOGIES LIMITED
Login to view more data
100 Translational Medicine associated with 4B TECHNOLOGIES LIMITED
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Sep 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
9
1
Preclinical
IND Application
1
3
Phase 1 Clinical
Phase 2 Clinical
1
2
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
FB-1006
Amyotrophic Lateral Sclerosis
More
Phase 2
Enrupatinib
 ( CSF-1R )		Amyotrophic Lateral Sclerosis
More
Phase 1
FB-1003
 ( TrkA )		-
Phase 1
FB-1001
 ( TrkB )		Optic Neuropathy, Ischemic
More
Phase 1
FB-1002
-
IND Application
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free